On December 28, 2023, Abion Inc. closed the transaction
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,945 KRW | -1.17% | -4.38% | -52.65% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
10,460 KRW | -3.15% | +25.72% | 167M | ||
2,945 KRW | -1.17% | -4.38% | 30.87M | ||
836 KRW | -1.42% | +5.96% | 70.37M | ||
1st Jan change | Capi. | |
---|---|---|
-52.65% | 30.87M | |
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
-8.85% | 1.78B |
- Stock Market
- Equities
- A229000 Stock
- News Gencurix Inc.
- Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.